I am responsible for the development and application of technologies in the area of precise genome engineering, human stem cell based disease models and transgenics in Discovery Sciences at Astrazeneca and the facilitating the exploitation of these technologies by our iMED disease focus areas for their drug discovery activities. I previously worked for many years at the Wellcome Trust Sanger Institute where I was involved in the generation of the large scale targeted mouse knockout resources of the IKMC and the IMPC and the generation of bespoke mouse and human stem cell models.
The World Advanced Therapies and Regenerative Medicine Congress and Exhibition is an international conference and exhibition featuring the latest in advanced therapies, bioengineering and surrounding technology. To attend the conference which features global leaders in the biopharma and regenerative medicine industries, there is a registration fee. The exhibition is free to visit.